Top compounds associated with response to TMEM63B


Feature Type Standardized
Nominal ANOVA
mRNA clofarabine CTRPv2 pan-cancer AAC -0.075 0.02
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.095 0.02
mRNA AZ628 GDSC1000 pan-cancer AAC -0.12 0.02
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.08 0.02
mRNA TKI258 CCLE pan-cancer AAC -0.12 0.02
mRNA ML312 CTRPv2 pan-cancer AAC 0.18 0.02
mRNA lapatinib CCLE pan-cancer AAC 0.11 0.02
mRNA Docetaxel gCSI pan-cancer AAC -0.14 0.02
mRNA KPT185 CTRPv2 pan-cancer AAC -0.094 0.02
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.094 0.02
Download CSV